Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Steven P. Treon, MD, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01614821
First received: May 17, 2012
Last updated: June 11, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)